Skip to main content
India Glycols Ltd logo

India Glycols Ltd — Investor Relations & Filings

Ticker · INDIAGLYCO ISIN · INE560A01023 LEI · 3358002YVDZUMPZLN823 BSE.NS Manufacturing
Open in API
Filings indexed 1,575 across all filing types
Latest filing 2022-11-14 Investor Presentation
Country IN India
Listing BSE.NS INDIAGLYCO

About India Glycols Ltd

https://www.indiaglycols.com/

India Glycols Ltd is a pioneer in the manufacturing of green technology-based chemicals. The company specializes in producing bio-based glycols, including monoethylene glycol (MEG), diethylene glycol (DEG), and triethylene glycol (TEG), utilizing renewable feedstock such as molasses. Its product portfolio extends to ethylene oxide derivatives, surfactants, and performance chemicals tailored for diverse applications in textiles, personal care, and oil and gas. Additionally, the company operates in the natural gums, industrial gases, and nutraceuticals sectors. IGL is recognized for its commitment to sustainable chemistry, being the first globally to commercialize the production of ethylene oxide and glycols from bio-ethanol. Its operations also include the production of extra neutral alcohol and high-quality spirits, serving both industrial and consumer markets with a focus on eco-friendly processes.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation dated November 14, 2022, addressed to stock exchanges and investors. It contains detailed financial performance data for Q2 FY23 and H1 FY23, business segment highlights, commodity price trends, and company overview. The text explicitly mentions 'Investor Presentation' in the subject line and the body, and the content is consistent with a presentation format including performance overview, segment performance, and strategic updates. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. It is not a regulatory filing or announcement of a report publication but a detailed presentation aimed at investors. Therefore, the appropriate classification is Investor Presentation (IP).
2022-11-14 English
Further to our letter dated 10th November, 2022 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Investor Presentation Classification · 100% confidence The document is an investor presentation dated 14th November 2022, explicitly titled 'Investor Presentation Q2 FY 2022-23'. It contains detailed financial performance data for Q2 and H1 FY23, business segment highlights, commodity price trends, and company overview. The text references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material information including investor presentations. The document is not a full annual or quarterly report but a presentation aimed at investors summarizing recent financial and operational performance. It is not an announcement of a report publication but the presentation itself. Therefore, the appropriate classification is Investor Presentation (IP).
2022-11-14 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results ....
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges informing about an upcoming Q2FY23 Results Conference Call scheduled for November 14, 2022. It includes details about the call, participants, and contact information. There is no actual financial data or results presented in the document, only an announcement of the conference call event. The document length is short (2508 characters), and it serves as a notification rather than a report or transcript. Therefore, it fits the category of a Call Transcript announcement or invitation, but since it is only an invitation and not the transcript itself, the best matching category is Call Transcript (CT) as it relates to the conference call event.
2022-11-10 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results ....
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges informing about an upcoming Q2FY23 Results Conference Call scheduled for November 14, 2022. It includes details about the call, participants, and contact information. There is no actual financial data or report content included, only an announcement of the conference call event. The document length is short (2508 characters) and it serves as a notification rather than a report or transcript. Therefore, it fits the category of a Call Transcript announcement or invitation. However, since it is an announcement of the call and not the transcript itself, the best fitting category is Call Transcript (CT) as it relates directly to the earnings call event.
2022-11-10 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter from India Glycols Limited addressed to stock exchanges, informing about an upcoming Q2FY23 Results Conference Call scheduled for November 14, 2022. It includes details about the call, participants, and contact information. The document does not contain any financial data or results itself, but rather announces the conference call event where such results will be discussed. This fits the definition of a Call Transcript (CT) announcement, but since it is only an invitation/intimation for the call and not the transcript itself, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations. The document length is short (2508 characters), and it is an announcement rather than a report or transcript. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-11-10 English
Further to letter dtd. 3.11.2022 and pursuant to Reg. 30 and Sch. III of SEBI Listing Regulations, we wish to inform you that the Board in its meeting held today i.e. 10.11.2022 has, inter-alia, ....
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement dated 10th November 2022 from India Glycols Limited addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting. It includes the approval of unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2022, along with limited review reports from statutory auditors. The document also mentions the re-appointment of an executive director. The financial data includes income statements, expenses, profit before tax, tax expenses, and earnings per share, indicating substantive financial information. The document is about quarterly and half-year financial results with actual financial data, not just an announcement of a report or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-11-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.